Aditxt CEO Clarifies NASDAQ Compliance and Capital Strategy
PremiumCompany AnnouncementsAditxt CEO Clarifies NASDAQ Compliance and Capital Strategy
29d ago
Appili Therapeutics mails circular in connection with special meeting
Premium
The Fly
Appili Therapeutics mails circular in connection with special meeting
1M ago
Aditxt  provides update on plans for 2024 year-end, accessing strategic capital
Premium
The Fly
Aditxt provides update on plans for 2024 year-end, accessing strategic capital
1M ago
Aditxt, Evofem enter second amendment to plan of merger
PremiumThe FlyAditxt, Evofem enter second amendment to plan of merger
2M ago
Aditxt files to sell $150M of common stock for holders
Premium
The Fly
Aditxt files to sell $150M of common stock for holders
2M ago
Aditxt sells 1.13M shares at $1.06 in registered direct offering
Premium
The Fly
Aditxt sells 1.13M shares at $1.06 in registered direct offering
3M ago
Aditxt, Inc. Merger with Evofem Biosciences Falls Through
PremiumCompany AnnouncementsAditxt, Inc. Merger with Evofem Biosciences Falls Through
6M ago
Aditxt, Inc. Announces Strategic Acquisition of Appili Therapeutics
Premium
Company Announcements
Aditxt, Inc. Announces Strategic Acquisition of Appili Therapeutics
7M ago
Aditxt  in pact to acquire Appili Therapeutics for 5.6c per share
Premium
The Fly
Aditxt in pact to acquire Appili Therapeutics for 5.6c per share
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100